Pharming Group (PHAR)
8.49
+0.46
(+5.73%)
USD |
NASDAQ |
Sep 27, 16:00
8.49
0.00 (0.00%)
After-Hours: 18:27
Pharming Group Cash and Short Term Investments (Quarterly): 160.32M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 160.32M |
March 31, 2024 | 201.97M |
December 31, 2023 | 213.42M |
September 30, 2023 | 197.56M |
June 30, 2023 | 192.37M |
March 31, 2023 | 184.78M |
December 31, 2022 | 207.34M |
September 30, 2022 | 188.70M |
June 30, 2022 | 189.96M |
March 31, 2022 | 189.67M |
December 31, 2021 | 191.92M |
September 30, 2021 | 183.31M |
June 30, 2021 | 188.39M |
March 31, 2021 | 206.25M |
December 31, 2020 | 205.16M |
September 30, 2020 | 181.74M |
June 30, 2020 | 171.83M |
March 31, 2020 | 147.61M |
December 31, 2019 | 74.35M |
September 30, 2019 | 68.89M |
June 30, 2019 | 72.64M |
March 31, 2019 | 73.29M |
December 31, 2018 | 91.87M |
September 30, 2018 | 82.53M |
June 30, 2018 | 75.78M |
Date | Value |
---|---|
March 31, 2018 | 72.07M |
December 31, 2017 | 70.37M |
September 30, 2017 | 45.08M |
June 30, 2017 | 28.60M |
March 31, 2017 | 29.24M |
December 31, 2016 | 33.54M |
September 30, 2016 | 18.81M |
June 30, 2016 | 23.82M |
March 31, 2016 | 31.17M |
December 31, 2015 | 34.60M |
September 30, 2015 | 39.22M |
June 30, 2015 | 27.79M |
March 31, 2015 | 32.62M |
December 31, 2014 | 41.57M |
September 30, 2014 | 29.99M |
June 30, 2014 | 35.82M |
March 31, 2014 | 25.58M |
December 31, 2013 | 23.43M |
September 30, 2013 | 17.14M |
June 30, 2013 | 16.98M |
March 31, 2013 | 23.18M |
December 31, 2012 | 6.974M |
September 30, 2012 | 1.886M |
March 31, 2012 | 10.53M |
December 31, 2011 | 4.895M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
68.89M
Minimum
Sep 2019
213.42M
Maximum
Dec 2023
177.28M
Average
189.19M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
uniQure NV | 524.43M |
ProQR Therapeutics NV | 103.07M |
Merus NV | 787.42M |
argenx SE | 3.102B |
Pharvaris NV | 368.28M |